More commentary on the compulsory license granted by the Indian Patent Office for Bayer’s drug Sorafenib Tosylate (Nexavar): I read your follow-up post on compulsory licensing. In it, you state that average income in India is $8000. I have no idea what your source is, but you are regrettably wrong. Average gross salary in India [...]

